Ophthalmic Business News

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Euan S. Thomson, PhD, president of ophthalmic devices and head of the digital business unit for Carl Zeiss Meditec, offers a look at the company’s goals.

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Cedric Francois, MD, PhD, Apellis co-founder and CEO, discusses study results and FDA communication regarding intravitreal pegcetacoplan for geographic atrophy.

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Ben Yerxa, PhD, acting CEO of Opus Genetics, discusses the company’s plans, including the beginning of trials of OPGx-001, designed to target the LCA5 gene.

NEW ORLEANS — At the Eyecelerator meeting here, Jason Menzo, chief operating officer at Foundation Fighting Blindness, discusses the RD Fund and how venture investing helps develop treatments for inherited retinal diseases.

NEW ORLEANS — LumiThera announced it has entered into a definitive merger agreement with Diopsys, according to a press release.

Survey data shows that, generally, investors do not understand how much their advisors charge for their services.

Over the next 5 years, the National Eye Institute is aiming to eliminate vision loss and improve quality of life through vision research, according to a press release from the organization.

Sanofi will invest up to $60 million in Gyroscope Therapeutics, with the proceeds funding the ongoing clinical trials of GT005 for geographic atrophy secondary to age-related macular degeneration, according to a press release.

Alcon intends to acquire Ivantis, the developer and manufacturer of the Hydrus microstent, according to a company press release.

NEW YORK — Richard C. Edlow, OD, discusses the increasing shift toward private equity in the second part of his presentation from OSN New York 2021.